The store will not work correctly when cookies are disabled.
3-(2-(1H-Tetrazol-5-ylthio)ethyl)-1H-indole
ID: ALA1812659
PubChem CID: 56666180
Max Phase: Preclinical
Molecular Formula: C14H14N2S
Molecular Weight: 242.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1c[nH]c(SCCc2c[nH]c3ccccc23)c1
Standard InChI: InChI=1S/C14H14N2S/c1-2-5-13-12(4-1)11(10-16-13)7-9-17-14-6-3-8-15-14/h1-6,8,10,15-16H,7,9H2
Standard InChI Key: AIAWOYMIYLQRCW-UHFFFAOYSA-N
Molfile:
RDKit 2D
17 19 0 0 0 0 0 0 0 0999 V2000
-5.0634 -25.8849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0646 -26.7121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3499 -27.1249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3517 -25.4721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6363 -25.8812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6360 -26.7122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8457 -26.9687 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3574 -26.2963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8461 -25.6242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5914 -24.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7846 -24.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5299 -23.8833 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.7231 -23.7115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1104 -24.2607 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6038 -23.8481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4321 -23.0411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3884 -22.9554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 8 1 0
8 9 2 0
9 5 1 0
4 1 1 0
9 10 1 0
5 6 1 0
10 11 1 0
11 12 1 0
2 3 1 0
12 13 1 0
13 14 1 0
3 6 2 0
1 2 2 0
5 4 2 0
6 7 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 242.35 | Molecular Weight (Monoisotopic): 242.0878 | AlogP: 3.83 | #Rotatable Bonds: 4 |
Polar Surface Area: 31.58 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.78 | CX LogD: 3.78 |
Aromatic Rings: 3 | Heavy Atoms: 17 | QED Weighted: 0.67 | Np Likeness Score: -0.48 |
References
1. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R.. (2011) Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators., 54 (15): [PMID:21726069] [10.1021/jm2006782] |